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Alistair W Stott1*, Roger W Humphry1*, George J Gunn1, Isabella Higgins2, Thia Hennessy3, Joe O’Flaherty4
and David A Graham4Abstract
Bovine viral diarrhoea virus (BVDV) causes an economically important endemic disease (BVD) of cattle in Ireland and
worldwide. Systematic eradication by detection and removal of infectious (BVDV carrier) cattle has been successful
in several regions. We therefore assessed the benefits (disease losses avoided) and costs (testing and culling
regime) of a potential eradication programme in Ireland. Published bio-economic models of BVDV spread in beef
suckler herds and dairy herds were adapted to estimate potential benefits of eradication in Ireland. A simple model
of BVDV spread in beef finisher herds was devised to estimate the benefits of eradication in this sector. A six year
eradication programme consisting of 5 inter-related virological and serological testing programmes is outlined and
costed. We found that the annualised benefits of BVDV eradication in Ireland exceeded the costs by a factor of 5 in
the beef suckler sector and a factor of 14 in the dairy sector. Corresponding payback periods were 1.2 and 0.5 years
respectively. These results highlight the significant economic impact of BVDV on the Irish cattle industry and
suggest a clear economic benefit to eradication using the proposed approach. This type of cost-benefit analysis is
considered an essential prerequisite prior to undertaking an eradication campaign of this magnitude.
Keywords: BVDV, Eradication, Cost benefit analysisBackground
Bovine viral diarrhoea virus (BVDV) causes BVD, one of
the most important diseases of cattle worldwide [1]. This
status results from a high prevalence in many countries
[2] combined with wide ranging and insidious impacts
on herd performance due to direct effects and to asso-
ciations with infertility and with a range of other dis-
eases through immunosuppression caused by BVDV [3].
The virus is spread primarily by individuals persistently
infected (PI) with the virus. These animals become
infected in-utero if their dam is either PI herself or sus-
ceptible to infection and exposed to the virus in early
pregnancy, becoming transiently infected followed by
seroconversion. Further details of the epidemiology and
economics of BVD are given by Houe [2]. Vaccines are
available but these add costs and farmers often fail to
appreciate their limitations and the importance of cor-
rect and appropriate use [4]. There is also evidence that* Correspondence: alistair.stott@sac.ac.uk; roger.humphry@sac.ac.uk
1Scottish Agricultural College, West Mains Road, Edinburgh, UK
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reproduction in any medium, provided the orcattle farmers do not routinely apply the biosecurity
practices necessary to prevent introduction of BVDV [5].
Given the above situation, systematic eradication of
BVDV from a country or region offers an alternative ap-
proach to control at farm level that has been successfully
applied in several European countries [6]. The most re-
cently reported national BVDV eradication programme
was described by Presi et al. [7]. They tested all Swiss
cattle for BVD virus by antigen-capture ELISA or RT-
PCR and culled all those individuals considered to be
persistently infected (PI). Prevalence of virus-positive
newborn calves fell from 1.8% to under 0.2% in two
years. However, although the science and technology of
BVDV eradication has been proven in Switzerland and
elsewhere, the socioeconomic arguments are less well
developed [8] but are likely to contribute greatly to a
successful eradication campaign.
More et al. [9] set priorities for non-regulatory animal
health in Ireland using Policy Delphi methods to elicit
opinion from experts and farmers. They identified BVD
as a disease that should be prioritized for action based
on the current threat to animal health and thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of resources available to support animal health. Barrett
et al. [10] subsequently reviewed the considerations for
BVD eradication from the livestock industry in Ireland.
They stressed the importance of cattle farming to the
Irish economy, the threat which BVD poses to it and the
potential for eradication provided that a systematic, ag-
gressive and well coordinated programme is followed.
This requires commitment from farmers, which in turn
is dependent on good information provided by influen-
tial persuaders of the farming community such as veter-
inary surgeons, the farming press and farm advisers.
This paper aims to provide an important part of this in-
formation i.e. a cost-benefit analysis (CBA) for a BVD
eradication scheme for Ireland.
The specific objectives of this study were two-fold.
The first was to estimate the benefits of freedom from
BVDV to the Irish beef and dairy sectors at farm level.
The annualised total current costs (losses) of BVD at
farm level were taken as the benefits of eradication. The
second objective was to estimate the costs of eradicating
BVD from Ireland and thus complete the CBA.
Methods
Herd size and structure
Data processing was carried out using SASW 9.1.3 (SAS In-
stitute Inc., Cary, NC, USA). Numbers of herds and aver-
age herd sizes by enterprise type were estimated from the
TB test returns collected in the year 2009. This method
excluded those farms with no animals on the day of test
and calves less than 6 weeks of age. Dealers, factory agents
and feedlot herds were also excluded as they are not sub-
ject to TB test. Enterprise type was obtained from Animal
Health Computer System test summary records.
Model and data sources
To assess the benefits of BVDV eradication we used the
bio-economic models described in Gunn et al. [11] and
Gunn et al. [1] to predict the average total costs of BVD
per cow per year in Irish suckler and dairy herds re-
spectively. These papers were based on epidemiological
and economic circumstances relevant to Scottish herds.
We therefore adapted these models to Irish conditions
by incorporating relevant Irish data. Unless otherwise
attributed, economic data were taken from the Irish Na-
tional Farm Survey (NFS) Data 2008 [12]. Although
more recent data are available for 2009, they were not
used here as 2009 was an exceptional year with output
levels significantly lower than normal; at the time the
current study was initiated, data for 2010 were not avail-
able. The NFS is a representative sample of Irish farms.
In general, there are 1,100 farms in the survey each year
which are weighted to represent the farming population
of approx 110,000 farms. The NFS is collected as part ofthe Farm Accountancy Data Network of the EU. Other
data were derived from the literature or databases cited,
from personal communication attributed or otherwise
from the expert knowledge of the authors themselves.
For beef finisher herds, not covered by the above mod-
els, we built a simple Markov chain model of the BVD
virus flow necessary at herd level to sustain the reported
prevalence of BVD in Ireland. Our model was built using
spreadsheet software [13]. It allowed a costing of BVD
impact to be estimated based on partial budgets adapted
from the suckler herd. It also provided an estimate of
the probability of BVD breakdown for use in the beef
suckler model. For a description and explanation of
Markov chain models in this context see Stott et al. [14].
BVD in beef suckler herds
Latest updates of the model of Gunn et al. [11]
described by Stott et al. [15] were incorporated. Main
parameter settings for this exercise are shown in
Table 1.
This model draws herds of fixed size at random from
a population of herds set up to represent the epidemio-
logical situation of beef suckler herds in the country or
region concerned (for further details of this see [16]).
This means that some herds are naïve, others contain
one or more PIs and the rest have variable proportions
of Ab + and susceptible individuals. The model then
tracks each herd forward in time for 10 annual steps. At
each step, animals enter and leave the herd, and calves
are born. The model adjusts heifer retention rates each
year to ensure that herd size remains constant. If the
herd contained a PI at the start of the simulation then
susceptible individuals may become transiently infected.
Some of these cases may be pregnant heifers or cows,
which may give birth to PI calves. It is also possible for
PIs to die prematurely or be sold so that no virus is then
circulating on the farm. However, it is also possible for
BVDV to arrive spontaneously as a consequence of bio-
security breakdown. The financial consequences of these
events such as the lost performance of transiently
infected calves, infertility of cows, premature culling, im-
munosuppression of calves, extra farm labour and veter-
inary costs etc. are accumulated over the 10 year period
and then annualised (their net present value is expressed
as an annuity based on the discount rate of 0.05) and
expressed per cow for easier interpretation. As the out-
come depends on a series of chance events, each iter-
ation of the (stochastic) model provided a different cost
of BVD. The model was therefore run many times (500
in this study) for a range of representative herd sizes to
build up a national picture of the average farm level dis-
ease costs.
Available data [17] suggests that 9.3% of suckler herds
in Ireland used BVD vaccine in 2010. To take this into
Table 1 Model parameters set to represent BVD in Irish suckler herds
Parameter Setting Comment
Epidemiological parameters:
Prevalence of antibody positive herds 0.75 Estimated by AHI, range thought likely to be 0.65-0.85*.
Prevalence of herds with one or more PI 0.25 Estimated by AHI, range thought likely to be 0.15-0.35*.
Risk of virus entry to a farm in any one year 0.19 Based on beef finisher model (see text)
Proportion of heifers becoming transiently infected if naive herd infected. 0.75 0.75 in Gunn et al. [11]
Proportion of cows becoming transiently infected if naive herd infected. 0.75 0.75 in Gunn et al. [11]
Financial parameters:
Sale value of normal male calf (€) 450 [12].
Sale value of normal female calf (€) 396 Relative to male weight in Gunn et al. [11]
Costs of immunosuppression effects (€/calf at risk) 3.06 Based on Gunn et al. [11]
Opportunity cost of farm labour (€/hour) 8.28 [12].
Replacement heifer cost (€) 1019 [12].
Value of cull cow (€) 793 [12].
Veterinary charges (€/hour or visit) 63 Estimate supplied by AHI
Other minor assumptions converted from £ to € 1.1322 Currency conversion factor
*Figures were derived primarily from unpublished data provided from a number of sources.
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herds. We assumed that vaccine costs €3/dose with cows
needing 1 dose and heifers 2 doses. The vaccine was
assumed to be 90% effective i.e. 0.9 of BVD susceptible
cows and heifers would become immune by its use
(based on [18]). Using outputs from model runs both
with and without vaccination, we were able to adjust our
estimates of the national losses due to BVD downwards
to account for current vaccine usage.
BVD in dairy herds
Further details and updates to the model of [1] are given
by [19]. Main parameter settings for this exercise are
shown in Table 2. The model works in similar fashion to
the beef suckler model but with a shorter (quarterly)
time step. These shorter time steps reflect the seasonal
nature of milk production in contrast to the annual cycle
of suckled calf production. Unlike the beef suckler
model, the starting epidemiological scenario is fixed,Table 2 Model parameters set to represent BVD in Irish dairy
Parameter
Prevalence of PI in purchased animals
Probability of biosecurity breakdown to BVD in any one year
Milk price (€/litre)
http://www.cso.ie/px/pxeirestat/Statire/SelectVarVal/Define.asp?maintable=AJ
Replacement heifer cost (€)
Value of cull cow (€)
Veterinary & Medicine charges (€/cow/year)with the model runs being performed twice, once as-
suming that the herd contains a PI cow at the start of
the simulation, the other assuming that it is naïve. As
before, BVD virus entry is still possible later on in the
simulation due to purchase of PI replacements and/or
other forms of biosecurity breakdown. By comparing the
losses due to BVD under these two extreme starting sce-
narios, an overall impression of the financial impact of
the disease in the dairy sector can be obtained. Vaccin-
ation was not an option in the dairy herd model. Esti-
mates of the impact of vaccination on losses due to BVD
in this sector were therefore extrapolated from the suck-
ler herd results based on an approximate 40% uptake at
herd level [17].
BVD in beef finisher herds
Given the nature of the disease, BVD virus will emerge
from PI calves born to cows in breeding herds. However,
some of these calves will be sold to store rearing/herds
Setting Comment
0.0075 Supplied by AHI (Table 1)
0.133 Based on Graham et al. [20].
0.294 CSO Ireland. Average 3.7% BF milk price for 2010.
M06
1,070 [12].
799 [12].
64 Estimate supplied by AHI
Table 3 Transition matrix for the Markov chain model of
beef finisher herds*
PI AB+Recent AB+Older Naïve Total
PI 0.43 0.57 0.00 0.00 1.0
AB + Recent 0.19 0.55 0.26 0.00 1.0
AB +Older 0.19 0.00 0.55 0.26 1.0
Naïve 0.19 0.00 0.00 0.81 1.0
* Rows represent herd types at time t and columns herd types at time t + 1.
For an explanation of herd types see text.
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loss through their own morbidity/mortality and through
spread of the virus to susceptible herd mates. It was
therefore important to estimate the additional financial
losses to BVD arising from these herds. A simplified ver-
sion of the models described above was therefore devel-
oped based on the same Markov chain principles applied
in them. Unlike the two breeding herd models, which
use Markov chains to follow the transitions of cattle be-
tween disease states (susceptible, PI, transiently infected
and immune) within a herd, this model follows the tran-
sition of herds between 4 states based on how recently
they were exposed to BVD virus and therefore on how
many susceptible animals they contain. In another con-
trast to the other two models, this one was first operated
in reverse i.e. starting with the expected proportion of
herds in some states as explained below; the model
determined the disease transmission probabilities re-
quired to achieve this outcome. The main output from
this Markov chain model was therefore its transition
matrix as well as the final state vector. The field based
assumptions on which this model was based and the
transition probabilities emerging from it were used in
the other two models, ensuring consistency between
them and allowing their epidemiological assumptions to
be matched with best estimates of the epidemiological
situation observed in the field. Once the transition
matrix was determined, the model could be run to pre-
dict the proportion of herds in each state. The number
of animals likely to be affected by BVD in various ways
could then be found and the financial losses arising from
them could be calculated.
Based on information supplied by AHI (D Graham,
unpublished data) for beef suckler herds (Table 1) it was
assumed that 0.75 of beef finisher herds would be anti-
body positive for BVDV with 0.25 of these containing a
PI animal (active infection and hence financial loss). It
was thought that in practice, very few beef or dairy herds
in Ireland would be entirely naïve i.e. contain no animals
that were Ab + and therefore immune due to exposure at
some point in the past to BVD virus. However, prelimin-
ary modelling work indicated that the cost of virus entry
into a herd with few (less than 0.25) Ab + animals would
be little less than a totally naïve herd. We therefore con-
ceived of 4 basic finisher herd types in terms of their ex-
tent of Ab + and PI animals. In addition to the 0.25 of PI
herds, other herds without a PI might be recently
exposed to virus (Ab +Recent) with about 0.75 of all ani-
mals Ab+. Other Ab+ herds may have been exposed less
recently (Ab +Older) and thus contain 0.25 animals Ab
+. The 0.25 of remaining herds i.e. with less than 0.25 of
animals Ab +would be designated naïve.
The transition matrix for the Markov chain model
which delivers 0.25 of herds PI and 0.25 of herds naïveis shown in Table 3. The spreadsheet’s inbuilt optimisa-
tion algorithm (solver) was used to obtain these para-
meters and hence derive the transition matrix. The
probability of all herds suffering a new virus entry each
year i.e. becoming PI if not already PI was found to be
0.19. The model also predicted that over the year, 0.32
herds would be Ab +Recent and 0.18 Ab +Older. The
full breakdown of our 4 herd types was therefore 0.25,
0.32, 0.18 and 0.25 for PI, Ab +Recent, Ab +Older and
naïve respectively. On this basis we were able to estimate
the overall annual cost of BVD in this sector based on
previously estimated losses from PIs (€594) and transi-
ently infected animals (€166). These estimates were
based on the assumed impacts of BVD on suckled calves
given in Gunn et al. [11] as updated by Stott et al. [15]
but applied to finishers. The healthy finisher was
assumed to weigh 600 kg (male) or 500 kg (female),
valued at €1.53/kg and €1.34/kg respectively (obtained
from CSO Ireland, [17] prices). The healthy finishers
were assumed purchased as stores weighing 250 kg and
220 kg for male and female respectively, growing at
0.93 kg and 0.86 kg per day. Transiently infected cattle
(TI) were assumed to lose 10% of these prices and
growth rates, while PIs would lose 20% (based on esti-
mates derived from expert panels consulted during the
construction of the model described by [11]). In
addition, TIs would attract extra vet bills of €11 and re-
quire additional farm labour of 1.1 hours (priced as
shown in Table 1). The equivalent figures for a PI were
€110 and 10 hours respectively.
Note that the data used to establish the number of
herds affected and the number of cattle at risk in beef
finisher herds were obtained from a breakdown of data
by herd size. The size categories were 1–20, 21–50, 51–
100, 101–250, 251–500 and >500. Cattle numbers were
assumed to be the mid-point in each category except for
the largest herd size category, which was assumed to be
500 head i.e. a conservative estimate. Herds categorized
as ‘beef ’ and as ‘other’ were assumed to be beef finisher
herds.
Model validation and sensitivity analysis
Validation of the two breeding herd models is described
in the source papers cited earlier [1,11]. In both cases,
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data of BVD outbreaks available at the time and were
also subject to iterative expert evaluation. Since then,
longitudinal data following the progress of BVD on com-
mercial farms in financial as well as epidemiological
terms are becoming available (Ganser et al., [21]). These
confirm the general extent and variability of the financial
impacts of BVD reflected in our model results. Further-
more, by linking our breeding herd models to field ob-
servation via our finisher herd model as described above,
we were able to establish a more coherent set of results
than would otherwise be possible, linked to the epi-
demiological situation observed in the field.
To investigate the influence of the value assigned to
each of the breeding herd model parameters, a sensitiv-
ity analysis was carried out by re-running the model
with each value individually increased by 10%. This iden-
tified the parameters with the greatest potential influ-
ence on results. This information when combined with
the expected variation in parameter estimates provided
an indication of how robust the BVD loss estimates were
likely to be. As a further guide to this, the breeding herd
model outputs at the lowest 10th percentile (i.e. 90% of
runs gave a higher loss than this) were used to estimate
the minimum (‘best case’) BVD losses.
Costs of eradicating BVD from Ireland
For the purposes of costing, a six-year programme for
BVD eradication from Ireland was broken down into five
test regimes with associated costs as follows, each ap-
plied to beef suckler and dairy herds. Any PIs in beef fin-
isher herds were assumed to clear through slaughter and
natural wastage.
Test 1 (Tag). This refers to the testing of ear tissue
samples collected from all calves by tissue test tags as
part of the official identification process and tested for
BVD virus (antigen or RNA). This was considered to be
carried out annually for the first three years of the
programme. Each test was estimated to cost €4 plus a
further €0.6 for the tag (an additional cost relative to the
cost of the conventional official identification tag). Given
that a PI cow will inevitably produce a PI calf, the dam
of any calf returning a negative virus result can therefore
also be considered to be non-PI. After one round of
negative testing, the calves and the majority of the adult
cattle (excluding those that did not produce a calf, or
that are male/bulls), can be considered to be non-PI.
The first round of testing will not give a clear indication
of the status of any yearlings in the herd (assumed to be
primarily female breeding stock). After a second round
of negative testing the following year, that part of the
adult herd that has produced a calf that year is again
also considered to not contain PIs. This year the yearling
stock from year 1 will also have entered the breedingherd, giving a result for these animals by trace back from
their offspring. The pool of animals without any BVDV
status is expected to shrink or disappear. After a third
clear round of testing, this group with no BVDV status
(based on direct testing or indirectly from their calves’
results) is expected to disappear in the majority of herds.
Where such animals exist, a ‘completion test’ (assumed
for this exercise to be based on blood samples collected
by the herd’s veterinary surgeon) will be carried out
(Test 2 below). Successful implementation of this ap-
proach is based on the assumption that parentage of
calves is correctly assigned.
Test 2 (Completion). This test will be applied to herds
with animals of unknown status after completion of the
test 1 phase. These animals will be identifiable for each
herd using the ICBF database. Based on analysis of current
herd data, it was assumed that after 3 years, 0.44 of dairy
herds and 0.33 of suckler herds will require a completion
test (Sean Coughlan, personal communication). It was fur-
ther assumed that on average three animals in each of
these herds will require extra blood tests at €4 each plus an
associated veterinary visit at €63. The small number of ani-
mals per herd assumed to require this test reflects the in-
fluence of the on-going testing programme, which will
limit the numbers of animals of unknown status remaining
at this stage of the programme.
Test 3 (PI removal). This test will be applied to herds
returning one or more virus positive calves under test 1.
It was assumed that 0.25 of herds (Table 1) have on
average 1.7 PI’s. This is the approximate number of PI’s
per herd needed to reach an animal level prevalence of
0.0075 (Table 1) if herd prevalence is 0.25. For simplicity
this process was assumed to occur in year 1 only, al-
though in practice the process would take longer but tail
off towards the end of the eradication programme. All
animals would be virus tested by blood sample in these
herds at the cost of €4 per test plus associated veterinary
visit cost of €63. Based on Presi et al. [7], 0.8 of PIs
detected would be calves. In the dairy herd all PI calves
were assumed to be disposed of at an average cost of
€60. For the adult PIs in the dairy herd, 0.9 were
assumed to be fit for slaughter at the normal cull value,
giving a net replacement cost of €271 (Table 2). The re-
mainder were assumed to attract a disposal charge of
€150. This resulted in an expected (probability weighted
average) cost of PI disposal in the dairy herd of €121/
head. This figure is made up of 0.8 calf disposals at -€60
=−€48 plus 0.18 (0.2x0.9) adults replaced fat at a net
cost of -€271 =−€48.78 and finally 0.02 (0.2x0.1) adults
replaced after disposal at a net cost of -€1220 =−€24.40.
A similar process was used for PI disposal cost in
suckler herds based on the same assumptions as for
dairy but with cow replacement price modifications as in
Table 1 (net replacement cost of a suckler cow is €226).
Table 4 Estimated current average annual losses from BVD in Irish dairy and suckler herds*
Herd type Mean cows/herd Number of herds Number of cows Costs/cow/yr (€) Total costs (€m)
Suckler 14.2 63,770 905,110 32 29.1
Dairy** 47.0 24,267 1,140,533 63 71.7
* Before accounting for the net benefit of vaccine use.
**Average of naïve herd costs at €57/cow/year and PI herd costs at €69/cow/year.
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be €112/head (0.8x-€60 + 0.18x-€226 + 0.02x-€1169).
Note that the costs and benefits of purchasing a replace-
ment foster calf were not included. For both dairy and
suckler herds it was assumed that virus positive cattle
would be removed within weeks of their being identified.
Test 4 (Surveillance). These costs cover the costs of
monitoring the national herds for re-entry of BVDV fol-
lowing successful completion of the test 1 regime. Each
year for years 4 to 6 of the programme, every dairy herd
was assumed to require three bulk tank milk (or first
lactation screen) BVD antibody tests at three to four-
monthly intervals costing €6/test. An equivalent blood
test was assumed to be carried out on 10 animals in
every beef suckler herd, at a cost of €4/test. No add-
itional veterinary related charges were included for the
suckler herds as this surveillance blood test could be
carried out at the TB test visit. However, a cost of €30 to
cover reagents, shipment etc. was assumed.
Test 5 (Confirm PI): It was assumed that in herds
where PIs were identified (Test 3), 0.7 of these PIs would
be subjected to a confirmatory virus test costing €4 with
an associated veterinary fee of €63.
The costs of all 5 tests were summed across six years
for dairy and beef sucklers and expressed in net presentTable 5 Sensitivity of suckler herd results in Table 4 to 10% i
Parameter
Epidemiological parameters:
Prevalence of antibody positive herds
Prevalence of herds with one or more PI
Risk of virus entry into a herd in any one year
Proportion of heifers that become transient infected if naïve herd infected
Proportion of cows that become transient infected if naïve herd infected
Financial parameters:
Sale value of normal male calf (€)
Sale value of normal female calf (€)
Costs of immunosuppression effects (€/calf at risk)
Opportunity cost of farm labour (€/hour)
Replacement heifer cost (€)
Value of cull cow (€)
Veterinary charges (€/hour or visit)
Other minor cost assumptions converted from £ to €
*See Table 1 for original parameter settings.value terms (NPV) using an assumed real interest rate of
0.05. The NPV was then taken as the estimated cost of
eradication. As the details of eradication are uncertain
and subject to change, costs are broken down into their
component parts in the results tables for each test so
that variations can be easily computed.
Results
BVD impact in beef suckler herds
The estimated average annual output losses due to BVD
in the Irish suckler herd are shown in Table 4. The aver-
age costs per cow per year in herds of different sizes are
aggregated in Table 4 to give a figure for the national
herd before accounting for the net benefit of vaccine
use. The average costs per cow per year in small herds
(<51 animals) was higher at €38/cow/year than in larger
herds at €29/cow/year. When the model was re-run as-
suming use of vaccine, losses due to BVDV per cow per
year including the cost of vaccine fell to €14/cow/year in
smaller herds and €10-11/cow/year in larger herds. Vac-
cination costs incorporated in these figures were €4.80/
cow/year. This equated to a net national saving of
€1.7 m/year due to the use of vaccines based on current
usage rates. The overall costs of €29 m/year shown in
Table 4 can therefore be reduced to €27 m/year.ncrease in the estimating model’s parameter settings
New setting* Percent change in costs/cow/year
0.825 0.6
0.275 7.4
0.209 7.8
0.825 1.3
0.825 5.1
495 5.5
436 5.2
3.4 1.4
9.11 5.6
1,121 7.5
872 −1.0
69 2.8
1.24 0.0
Table 6 Sensitivity of dairy herd results in Table 4 to 10% increase in the estimating model’s parameter settings
Parameter New setting* Naïve herd Percent change in costs /cow/year
Prevalence of PI in purchased animals 0.00825 1.0 0.5
Probability of biosecurity breakdown to BVD in any one year 0.1463 4.3 1.7
Milk price (€/litre) 0.323 6.5 6.4
Replacement heifer cost (€) 1,177 2.1 1.0
Value of cull cow (€) 879 −0.1 −0.3
Veterinary & Medicine charges (€/cow) 70 −1.5 0.0
*See Table 2 for original parameter settings.
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changes in model parameters given in Table 1 are shown
in Table 5. The sensitivity analysis was based on a beef
suckler herd of average size (14 cows). The average out-
put loss from BVD in this herd was €30.49/cow/year.
The most sensitive assumptions are those relating to risk
of virus entry, prevalence of herds with one or more PIs
and the cost of a replacement heifer. The ‘best case’
(10th percentile) output loss from this model averaged
€3.18/cow/year over the various herd size assumptions.
This gave a total annual cost for the sector of approxi-
mately €3 m.
BVD impact in dairy herds
Table 4 also shows the estimated average annual output
losses due to BVD in the Irish dairy herd, assuming that
herds are either all naïve at the start of the simulated
epidemic or already contain a PI cow (infected herd). As
approximately equal proportions (0.25, 0.25) of herds
are thought to be naïve or contain a PI, we took the
mean of these 2 estimates (€72 m) as the approximate
average annual losses due to BVD in the Irish dairy in-
dustry i.e. about €63/cow. Vaccine use is considered to
be about four times greater in Irish dairy herds (assumed
40% of herds) than it is in Irish suckler herds. A propor-
tionately greater saving (24%) due to vaccine use may
therefore be expected in the dairy sector compared to
the beef suckler sector. Allowing for vaccination use
then reduces the national annual output loss due to
BVD to €55 m i.e. €48/cow.
Sensitivity analysis for the dairy sector results appear
in Table 6. This analysis shows that results are mostTable 7 Estimated current average annual BVD losses in Irish
Herd type* Number of herds affected Cattle at
PI 6,387
AB+ Recent 1,532
AB+Older 885
Naive 1,208
Total: 10,012
*PI-Herds with a PI, AB + antibody positive. For further description of herd types seesensitive to milk price and biosecurity breakdown in
naïve herds. The ‘best case’ (10th percentile) output loss
from this model averaged €52/cow/year over the various
herd size and starting scenario assumptions. This gave a
total annual cost for the sector of approximately €60 m
(€46 m after allowing for vaccine use).
BVD impact in beef finisher herds
A summary of the impacts of BVD across this sector in
Ireland are given in Table 7. The majority of the losses
accrue perhaps surprisingly to herds that have had no
recent exposure to the virus (AB+Older and Naïve).
This is because although the risks of exposure in any
one year are not high (0.19) there are a lot of herds in
this category (0.43) and the high numbers of susceptible
animals in these herds make the losses per head greater
should infection be introduced. In beef finisher herds
containing a PI, other animals are assumed to have
already acquired immunity and the apparently low costs
per animal are a reflection of this. The final category (re-
cently exposed AB+Recent) have relatively few animals
that are not immune and therefore if re-exposed to the
virus, average losses per head are lower. The total num-
ber of animals in this sector is approximately 1.06 m,
giving an overall annual loss from BVD of 19 €/head in
this sector.
Costs of BVD eradication
A breakdown of the cost calculations for each of the 5
tests needed to establish freedom from BVDV in Irish
suckler herds are shown in Table 8. A similar breakdown
for dairy herds is shown in Table 9. These results formbeef finisher herds
risk (head) Costs/head/yr (€) Total costs (€m)
265,078 18 4.7
107,218 25 2.7
36,712 125 4.6
50,150 166 8.4
459,158 20.4
text.
Table 8 Predicted costs/year for each test required during BVDV eradication from Irish suckler herds
T* Number
of herds
Tests/
herd
Tests Cost/
Test (€)
Vet
Fee (€)
Culls Costs/
cull (€)
Other
Fee (€)
Total Costs (€m)
Tests Vet Replace PIs Other fees Total
1 63,770 14.4 918,288 4.6 4.22 4.22
2 21,044 3.0 63,132 4.0 63 0.25 1.33 1.58
3 15,943 50.1 798,719 4.0 63 27,102 112 3.20 1.00 3.04 7.24
4 63,770 10.0 637,700 4.0 30 2.55 1.91 4.46
5 15,943 1.2 18,972 4.0 63 0.08 1.20 1.28
*Test 1: Tag calves, 2: Herd completion, 3: Remove PIs, 4: Surveillance, 5: Confirm PIs.
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Tables 10 and 11 for suckler herds and dairy herds re-
spectively. The annuity equivalents of the NPVs were ap-
proximately €6 m and €5 m for suckler and dairy herds
respectively. Overall the total cost of eradication over
the 6 year period was €55 m (€32 m suckler, €23 m
dairy).
CBA of BVDV eradication from Ireland
Table 12 compares the costs of eradication with the ben-
efits of BVD losses saved first by comparing annual ben-
efits with annualised costs (annuity equivalent of NPV)
and then as a pay-back period over the six year period of
the proposed programme. The annual benefits of eradi-
cation exceed the annual costs by a factor of 5 in the
suckler herds and by a factor of 14 in dairy herds. The
pay-back period is the NPV of eradication costs divided
by the annualised BVD losses i.e. the length of time it
will take to recoup the total (6-year) costs of eradication
from the (annual) BVD losses. The eradication costs in
the suckler herd over a six year programme are approxi-
mately equal to the losses that occur each year. In the
dairy sector, the benefit is even greater, with the costs of
the 6 year eradication programme equalling less than
40% of the losses that occur each year. In the absence of
a programme, these losses can be assumed to continue
year on year for the foreseeable future. Even if the ‘best
case’ assumptions are made about the breeding herd
BVD losses and any losses in finisher herds are assumed
negligible, eradication costs are still covered by the bene-
fits. In this case the total benefits (BVD losses saved) are
€49 m (€3 m from suckler herds plus €46 m from dairyTable 9 Predicted costs/year for each test required during BV
T* Number
of herds
Tests/
herd
Tests Cost/
Test (€)
Vet
Fee (€)
Culls C
cu
1 24,267 47.0 1,140,549 4.6
2 10,677 3.0 32,032 4.0 63
3 6,067 142.0 861,479 4.0 63 10,313 1
4 24,267 9.0 218,403 6.0
5 6,067 1.2 7,219 4.0 63
*Tests as for Table 8.herds). This gives a cost benefit ratio of almost 5 and
payback of total eradication costs of just over 1 year.
Discussion
Our results predict that benefits of BVDV eradication
from Ireland using the proposed approach far exceed the
costs. This result occurred despite building in various
conservative assumptions about the cost of eradication.
First, the completion test (test 2) may be carried out as
part of routine herd visits or at TB test, thus reducing or
removing the veterinarian’s visiting charge. The number
of herds requiring a completion test is probably overesti-
mated as it was based on current figures rather than the
reduced number once more animals moving have a tag
test result confirming them as non-PI. Test 3 (PI re-
moval) and test 5 (confirm PI) may also be less costly as
cheaper alternatives to the blood testing protocol may
be incorporated in the programme. Surveillance test
costs (test 4) may also be reduced by pooling samples.
Various other costs may be reduced by the economies
of scale associated with a nationwide eradication
programme. On the other hand, we only included direct
financial costs in our assessment of the costs of eradica-
tion. There will be other costs that are less easy to assess
but could increase costs substantially. For example, pre-
mature culling implies loss of future profits that are not
captured in the net cash cost of replacement. Such costs
are often included as retention pay-off (RPO), which
estimates the difference in profit between replacement at
the optimal time and immediate replacement [22]. How-
ever, in the case of the immediate replacement of a PI,
the RPO will probably be negative due to the futureDV eradication from Irish dairy herds
osts/
ll (€)
Other
Fee (€)
Total Costs (€m)
Tests Vet Replace PIs Other fees Total
5.25 5.25
0.13 0.67 0.80
21.18 3.45 0.38 1.25 5.08
1.31 1.31
0.03 0.45 0.48
Table 10 Net present value (NPV) cashflows for proposed BVD eradication programme in Irish suckler herds (€m)
Tests:
Year 1 2 3 4 5 Total*
Tag calves Herd completion Remove PI Surveillance Confirm PI
1 4.22 7.24 1.28 12.74
2 4.22 4.22
3 4.22 1.58 5.80
4 4.46 4.46
5 4.46 4.46
6 4.46 4.46
NPV: 31.47
*Row totals are before discounting and therefore their sum exceeds the NPV.
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benefits (BVD losses avoided) side. Any outstanding
costs not captured by our direct approach (e.g. oppor-
tunity costs of farm labour, scheme administration costs
etc.) are likely to be outweighed by uncaptured benefits
of eradication such as improved animal welfare, better
biosecurity, enhanced reputation of the farming sector
and the experiential knowledge gained by those involved
[23].
It is possible that our estimates of the BVD losses
saved (benefits) may not be fully realised in practice.
However, even if we took the losses at the 10th percentile
of our range of loss estimates rather than the mean, the
cost benefit ratio and payback periods were still attract-
ive. Furthermore, based on our sensitivity analysis, sub-
stantially lower BVD losses saved would arise either
from lower prevalence of PIs/risk of virus entry and/or
from lower commodity prices. In the first case, lower
BVD prevalence will reduce eradication costs thus par-
tially offsetting the impact of reduced losses avoided. In
the second case, commodity prices have risen since the
price assumptions used here were taken. Nevertheless, it
will always be difficult to assess ex-ante the benefits of
an eradication programme. In other countries whereTable 11 Net present value of proposed BVD eradication prog
Test
Year 1 2 3
Tag calves Herd completion Remo
1 5.25 5.08
2 5.25
3 5.25 0.80
4
5
6
NPV:
*Row totals are before discounting and therefore their sum exceeds the NPV.BVD eradication has been implemented, ex-post assess-
ment of progress has been largely in epidemiological ra-
ther than economic terms (e.g. [7]). A notable exception
is Norway [23]. In this case, benefits (measured as the
difference between observed and expected BVD losses
had no eradication scheme been in place) exceeded costs
in all years reported (1993 to 2002). The cost benefit
ratio of just over 1 in 1993, peaked at 12 in 2000. These
results are comparable with our own. The Scottish Gov-
ernment have provided an ex-ante financial assessment
of their BVD eradication programme [24,25]). However,
their results are less comparable with those reported
here since they are based on assumed impacts on farm
business performance rather than on the cost and bene-
fits of BVD eradication per se. Even so, the Scottish Gov-
ernment report a positive economic assessment and
their eradication programme is currently underway.
Despite our positive outcome in favour of BVD eradi-
cation from Ireland, investment appraisal is hampered
by the different basis of the cost and benefit calculations.
Costs of eradication are finite, can be fairly accurately
estimated and must be incurred by all concerned in ad-
vance and without guarantee of success. By contrast, the
benefits of eradication are based on uncertain and oftenramme in Irish dairy herds (€m)
s:
4 5 Total*
ve PI Surveillance Confirm PI
0.48 10.81
5.25
6.05
1.31 1.31
1.31 1.31
1.31 1.31
23.36
Table 12 CBA and payback period for eradication of
BVDV from Ireland
Suckler Dairy Sector:
Beef
Total
Benefit (BVD losses saved*) (€m/year) 27 55 20 102
Cost (test costs) (€m/year) 6 4 10
Benefit cost ratio 5 14 10
Total eradication costs (NPV €m) 32 23 55
Payback period (NPV/annual benefit)
in years
1.2 0.4 0.5
*includes adjustment for estimated savings through use of vaccination.
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http://www.irishvetjournal.org/content/65/1/12hidden losses from BVD that will vary considerably be-
tween farms but persist indefinitely in the absence of
control. There is the added difficulty that the incentives
to eradicate will vary as an eradication scheme pro-
gresses and may mitigate against progress at the start
when risks of re-infection are high and at the end when
the marginal cost of eradication increase with the pro-
portion of difficult cases remaining [1]. Furthermore, the
attitudes of farmers towards BVD eradication vary
widely between country, region and locality and are an
important factor in the success of eradication campaigns
[8]. It follows that experience of other countries and
CBA are just parts of the process needed to implement
a successful eradication campaign. However, a high
benefit-cost ratio is a highly desirable prerequisite. This
assessment of the components of this ratio is therefore
important.
The estimated output losses due to BVD in Ireland
provided here are expected results i.e. the average of a
large number of model runs and yet we do not provide
any estimates of uncertainty. The models used do cap-
ture some of the uncertainty associated with the prob-
abilistic processes of the disease (e.g. uncertainty of a PI
being born to a transiently infected cow). They do not
however take into account the uncertainty associated
with any other factors (e.g. financial assumptions).
Therefore it is inappropriate to provide summaries of
uncertainty since they would be insufficiently conserva-
tive (i.e. too small) and imply a higher degree of confi-
dence than is warranted. Instead we have provided a
sensitivity analysis for each of the main assumptions in
our models. Our results are only sensitive to one or two
key epidemiological and financial assumptions such as
the probability of virus entry (biosecurity breakdown),
milk prices and replacement heifer costs. However, as
benefits greatly exceed costs in this exercise these are
not as critical as they might have been if costs and bene-
fits had been more closely matched.
It is important to consider that the eradication
programme may not be successful or BVD may re-enter
the country after eradication leading to renewed losses.
To prevent this latter occurrence, greater expendituremay be required on biosecurity precautions. This may
increase the costs of eradication above those recorded
here. However, it may also give collateral benefits. The
productivity gains that accompany BVD eradication may
depress market prices and so partially offset the benefits
to farmers of eradication as shown by [19] for Scotland.
This may be less of a problem for a predominantly food
exporting country like Ireland, especially if BVD eradica-
tion gives a competitive advantage in overseas markets
where BVD persists. The productivity gains are likely to
reduce the environmental impact of agriculture through
reduced emissions of greenhouse gases per unit of prod-
uct [26]. Freedom from BVD will also bring animal wel-
fare benefits.
Conclusions
We estimated that the annualised benefits of eradicating
BVDV from Ireland exceeded the costs by a factor of 5
in the suckler beef sector and by a factor of 14 in the
dairy sector. This is an important prerequisite for a suc-
cessful eradication campaign.
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